MLSS: Q3 2025 saw stable revenue, reduced expenses, and improved margins amid ongoing transformation
Czytanie zajmuje mniej niż 1 minutę
Stable Q3 2025 revenue was supported by international dental and medical growth, while operating expenses fell by over $500K year-over-year. Gross margin remained strong at 70%, and operational transformation is expected to drive future margin improvement and value creation.
Original document: Milestone Scientific, Inc. [MLSS] SEC 8-K Current Report — Nov. 14 2025
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
© AI-generated summary is provided by Quartr